1,116 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Acquired by Park Edge Advisors LLC

Park Edge Advisors LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 1,116 shares of the medical equipment provider's stock, valued at approximately $583,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Berbice Capital Management LLC bought a new stake in Intuitive Surgical in the fourth quarter valued at approximately $26,000. Godsey & Gibb Inc. increased its position in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock worth $29,000 after buying an additional 35 shares during the period. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical during the third quarter worth $33,000. Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical in the fourth quarter valued at $36,000. Finally, Capital Performance Advisors LLP bought a new stake in Intuitive Surgical during the third quarter valued at $38,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

ISRG traded down $24.61 during mid-day trading on Friday, reaching $584.05. 4,350,539 shares of the stock were exchanged, compared to its average volume of 1,342,626. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The stock has a market capitalization of $208.03 billion, a PE ratio of 93.90, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The company has a 50 day moving average price of $547.16 and a two-hundred day moving average price of $504.78.

Insider Buying and Selling

In other news, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the transaction, the chief executive officer now directly owns 24,219 shares of the company's stock, valued at $12,391,166.97. This represents a 42.84 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,730,093.55. This trade represents a 2.99 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 42,475 shares of company stock worth $22,070,807. 0.90% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on ISRG. Mizuho lifted their price objective on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Piper Sandler reissued an "overweight" rating and issued a $670.00 price target (up from $538.00) on shares of Intuitive Surgical in a research note on Friday. Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Tuesday, November 19th. Evercore ISI reiterated a "cautious" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Royal Bank of Canada raised their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an "outperform" rating in a report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $583.83.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.